scispace - formally typeset
H

Hideaki Shimada

Researcher at Toho University

Publications -  396
Citations -  9535

Hideaki Shimada is an academic researcher from Toho University. The author has contributed to research in topics: Cancer & Esophageal cancer. The author has an hindex of 46, co-authored 378 publications receiving 8615 citations. Previous affiliations of Hideaki Shimada include Kitasato University & Chiba University.

Papers
More filters
Journal ArticleDOI

Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association

TL;DR: Although no prospective trial has yet been completed to evaluate the clinical significance of these serum markers, this literature survey suggests that combinations of CEA, CA19-9, and CA72-4 are the most effective ways for staging before surgery or chemotherapy.
Journal ArticleDOI

High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer

TL;DR: A high preoperative NLR may be a convenient biomarker to identify patients with a poor prognosis after resection for primary gastric cancer, and was an independent risk factor for reduced survival on multivariate analysis.
Journal ArticleDOI

Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer.

TL;DR: The findings show that LADG with extraperigastric lymph node dissection is a safe and less invasive alternative to the open procedure.
Journal Article

Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer.

TL;DR: It is demonstrated that the kinetochore protein CENP-A was overexpressed in all of 11 primary human colorectal cancer tissues, suggesting that overexpression of CENp-A could play an important role for aneuploidy in coloreCTal cancers.
Journal ArticleDOI

Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma

TL;DR: In this paper, the authors analyzed the clinicopathologic significance and prognostic value of platelet counts in patients with esophageal cancer using a Cox's proportional hazards model and showed that a high platelet count is associated with tumor progression and poor survival.